Strategies in biomimetic surface engineering of nanoparticles for biomedical applications.

Engineered nanoparticles (NPs) play an increasingly important role in biomedical sciences and in nanomedicine. Yet, in spite of significant advances, it remains difficult to construct drug-loaded NPs with precisely defined therapeutic effects, in terms of release time and spatial targeting. The body is a highly complex system that imposes multiple physiological and cellular barriers to foreign objects. Upon injection in the blood stream or following oral administation, NPs have to bypass numerous barriers prior to reaching their intended target. A particularly successful design strategy consists in masking the NP to the biological environment by covering it with an outer surface mimicking the composition and functionality of the cell's external membrane. This review describes this biomimetic approach. First, we outline key features of the composition and function of the cell membrane. Then, we present recent developments in the fabrication of molecules that mimic biomolecules present on the cell membrane, such as proteins, peptides, and carbohydrates. We present effective strategies to link such bioactive molecules to the NPs surface and we highlight the power of this approach by presenting some exciting examples of biomimetically engineered NPs useful for multimodal diagnostics and for target-specific drug/gene delivery applications. Finally, critical directions for future research and applications of biomimetic NPs are suggested to the readers.

[1]  A. M. Carmona-Ribeiro,et al.  Adsorption behavior of DODAB/DPPC vesicles on silica. , 2007, Journal of colloid and interface science.

[2]  S. Ramakrishnan,et al.  Synthesis and vesicular polymerization of novel counter‐ion polymerizable/crosslinkable surfactants , 2004 .

[3]  A. El-Aneed,et al.  Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances. , 2010, Nanomedicine.

[4]  A. Charrier,et al.  Direct stabilization of a phospholipid monolayer on H-terminated silicon. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[5]  S. Nishimura,et al.  Importance of sialic acid residues illuminated by live animal imaging using phosphorylcholine self-assembled monolayer-coated quantum dots. , 2011, Journal of the American Chemical Society.

[6]  Wean Sin Cheow,et al.  Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles. , 2011, Colloids and surfaces. B, Biointerfaces.

[7]  I. García,et al.  Glyconanoparticles: multifunctional nanomaterials for biomedical applications. , 2010, Nanomedicine.

[8]  D. Yan,et al.  Supramolecular and biomimetic polypseudorotaxane/glycopolymer biohybrids: synthesis, glucose-surfaced nanoparticles, and recognition with lectin. , 2008, The journal of physical chemistry. B.

[9]  Y. Chiu,et al.  Self-assembled biomimetic monolayers using phospholipid-containing disulfides. , 2005, Biomaterials.

[10]  J. Benoit,et al.  The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting. , 2010, Nanomedicine.

[11]  S. Armes,et al.  Controlling polymersome surface topology at the nanoscale by membrane confined polymer/polymer phase separation. , 2011, ACS nano.

[12]  C. Tribet,et al.  Enthalpy of interaction and binding isotherms of non-ionic surfactants onto micellar amphiphilic polymers (amphipols). , 2007, Langmuir : the ACS journal of surfaces and colloids.

[13]  R. Kontermann,et al.  Targeted delivery of SiRNA to CD33-positive tumor cells with liposomal carrier systems. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Y. Gohon,et al.  Complexation of integral membrane proteins by phosphorylcholine-based amphipols. , 2007, Biochimica et biophysica acta.

[15]  Tongwen Xu,et al.  Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives. , 2011, Chemical Society reviews.

[16]  Jie Pan,et al.  Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel. , 2010, Biomaterials.

[17]  Hakho Lee,et al.  Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection. , 2010, Nature nanotechnology.

[18]  D. Buxton The promise of nanotechnology for heart, lung and blood diseases , 2006, Expert opinion on drug delivery.

[19]  Che-Ping Lin,et al.  Preparation and characterization of poly (2-methacryloyloxyethyl phosphorylcholine)-block-poly(D,L-lactide) polymer nanoparticles , 2007 .

[20]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[21]  T. Emrick,et al.  End-functionalized phosphorylcholine methacrylates and their use in protein conjugation. , 2008, Biomacromolecules.

[22]  A Watanabe,et al.  Interaction between phospholipids and biocompatible polymers containing a phosphorylcholine moiety. , 1991, Biomaterials.

[23]  S. Parveen,et al.  Evaluation of cytotoxicity and mechanism of apoptosis of doxorubicin using folate-decorated chitosan nanoparticles for targeted delivery to retinoblastoma , 2010, Cancer nanotechnology.

[24]  I. Banerjee,et al.  Folate receptor targeted, carboxymethyl chitosan functionalized iron oxide nanoparticles: a novel ultradispersed nanoconjugates for bimodal imaging. , 2011, Nanoscale.

[25]  M Ferrari,et al.  Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Mansoor M. Amiji,et al.  Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery , 2007, Pharmaceutical Research.

[27]  Lei Zhu,et al.  Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery. , 2011, Biomacromolecules.

[28]  Serena Mazzucchelli,et al.  HER2 expression in breast cancer cells is downregulated upon active targeting by antibody-engineered multifunctional nanoparticles in mice. , 2011, ACS nano.

[29]  J. Hilborn,et al.  Preparation of hyaluronic acid nanoparticles via hydrophobic association assisted chemical cross-linking—an orthogonal modular approach , 2011 .

[30]  C. Cai,et al.  Synthesis of magnetic, fluorescent and mesoporous core-shell-structured nanoparticles for imaging, targeting and photodynamic therapy , 2011 .

[31]  Hua Ai,et al.  Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. , 2011, Accounts of chemical research.

[32]  L. Ji,et al.  γ-Cyclodextrin–folate complex-functionalized quantum dots for tumor-targeting and site-specific labeling , 2011 .

[33]  K. Ishihara,et al.  Artificial cell membrane-covered nanoparticles embedding quantum dots as stable and highly sensitive fluorescence bioimaging probes. , 2008, Biomacromolecules.

[34]  A. Goyal,et al.  Advances in Novel Drug Delivery Strategies for Breast Cancer Therapy , 2010, Artificial cells, blood substitutes, and immobilization biotechnology.

[35]  Mykhailo V Bondar,et al.  Folate receptor-targeted aggregation-enhanced near-IR emitting silica nanoprobe for one-photon in vivo and two-photon ex vivo fluorescence bioimaging. , 2011, Bioconjugate chemistry.

[36]  Michael J Sailor,et al.  Biomimetic amplification of nanoparticle homing to tumors , 2007, Proceedings of the National Academy of Sciences.

[37]  Jeong Hyun Yeum,et al.  Preparation and characterization of MRI-active gadolinium nanocomposite particles for neutron capture therapy , 2011 .

[38]  B. Liu,et al.  Folic acid-functionalized two-photon absorbing nanoparticles for targeted MCF-7 cancer cell imaging. , 2011, Chemical communications.

[39]  G. Ponchel,et al.  Synthesis and characterization of novel poly(γ‐benzyl‐L‐glutamate) derivatives tailored for the preparation of nanoparticles of pharmaceutical interest , 2007 .

[40]  C. Galbán,et al.  Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. , 2011, Biomaterials.

[41]  Christopher J. Cheng,et al.  Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides. , 2011, Biomaterials.

[42]  K. Peter,et al.  Enzymatic Single-Chain Antibody Tagging: A Universal Approach to Targeted Molecular Imaging and Cell Homing in Cardiovascular Disease , 2011, Circulation research.

[43]  Vladimir P Torchilin,et al.  Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[44]  S. Saavedra,et al.  Preparation and characterization of poly(lipid)-coated, fluorophore-doped silica nanoparticles for biolabeling and cellular imaging. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[45]  J. Spatz,et al.  Conjugation of peptides to the passivation shell of gold nanoparticles for targeting of cell-surface receptors. , 2010, ACS nano.

[46]  Robert Blumenthal,et al.  Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. , 2009, Critical reviews in therapeutic drug carrier systems.

[47]  S. Armes,et al.  Preparation of biocompatible sterically stabilized latexes using well-defined poly(2-(methacryloyloxy)ethyl phosphorylcholine) macromonomers. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[48]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[49]  Jin Sun,et al.  Long-circulating Targeted Nanoparticles for Cancer Therapy , 2010 .

[50]  Suntharampillai Thevuthasan,et al.  PEGylated inorganic nanoparticles. , 2011, Angewandte Chemie.

[51]  A. Müller,et al.  Glycopolymer-grafted polystyrene nanospheres. , 2011, Macromolecular bioscience.

[52]  K. Ishihara,et al.  Polymeric Lipid Nanosphere Consisting of Water-Soluble Poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) , 1999 .

[53]  A. M. Carmona-Ribeiro Lipid-based Biomimetics in Drug and Vaccine Delivery , 2010 .

[54]  L. Bergström,et al.  A membrane-reconstituted multisubunit functional proton pump on mesoporous silica particles. , 2009, ACS nano.

[55]  J. Tour,et al.  Noncovalent functionalization of carbon nanovectors with an antibody enables targeted drug delivery. , 2011, ACS nano.

[56]  S. Esener,et al.  Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells. , 2010, Molecular pharmaceutics.

[57]  I. Chen,et al.  The surface modification of silver nanoparticles by phosphoryl disulfides for improved biocompatibility and intracellular uptake. , 2008, Biomaterials.

[58]  C. Innocenti,et al.  Water-dispersible sugar-coated iron oxide nanoparticles. An evaluation of their relaxometric and magnetic hyperthermia properties. , 2011, Journal of the American Chemical Society.

[59]  Jiehua Li,et al.  Synthesis and micellization of new biodegradable phosphorylcholine-capped polyurethane , 2011 .

[60]  Xin Gao,et al.  Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy. , 2011, Biomaterials.

[61]  T. Nishikubo,et al.  Novel Synthesis of Polymers with Well-Defined Structures Based on Selective Reaction of Cyclic Sulfides and Cyclic Ethers Catalyzed by Quaternary Onium Salts , 2009 .

[62]  Vincent M Rotello,et al.  Intracellular delivery of a membrane-impermeable enzyme in active form using functionalized gold nanoparticles. , 2010, Journal of the American Chemical Society.

[63]  Forrest M Kievit,et al.  Surface engineering of iron oxide nanoparticles for targeted cancer therapy. , 2011, Accounts of chemical research.

[64]  C. Tribet,et al.  Thermodynamic characterization of the exchange of detergents and amphipols at the surfaces of integral membrane proteins. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[65]  S. Feng,et al.  Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. , 2010, International journal of pharmaceutics.

[66]  S. Armes,et al.  Novel biocompatible phosphorylcholine-based self-assembled nanoparticles for drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[67]  Xing-Jie Liang,et al.  Theranostic nanoparticles engineered for clinic and pharmaceutics. , 2011, Accounts of chemical research.

[68]  V. Torchilin,et al.  Phospholipid–polyethylenimine conjugate-based micelle-like nanoparticles for siRNA delivery , 2011, Drug Delivery and Translational Research.

[69]  S. Vyas,et al.  Biomimetic solid lipid nanoparticles for oral bioavailability enhancement of low molecular weight heparin and its lipid conjugates: in vitro and in vivo evaluation. , 2011, Molecular pharmaceutics.

[70]  David E Cliffel,et al.  Nanoparticle-based biologic mimetics. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[71]  Y. Namiki,et al.  Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring. , 2011, Accounts of chemical research.

[72]  Valentina Cauda,et al.  Colchicine-loaded lipid bilayer-coated 50 nm mesoporous nanoparticles efficiently induce microtubule depolymerization upon cell uptake. , 2010, Nano letters.

[73]  Udo Bakowsky,et al.  Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery. , 2010, Biomaterials.

[74]  S. Kiatkamjornwong,et al.  Polymer brushes in nanopores surrounded by silicon-supported tris(trimethylsiloxy)silyl monolayers. , 2007, Journal of colloid and interface science.

[75]  T. Yamauchi,et al.  Preparation and properties of biocompatible polymer-grafted silica nanoparticle , 2006 .

[76]  Liangfang Zhang,et al.  Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy. , 2011, Molecular pharmaceutics.

[77]  C. Galbán,et al.  Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles. , 2011, Biomaterials.

[78]  Synthesis, structure and surface dynamics of phosphorycholine functional biomimicking polymers. , 1998, Biomaterials.

[79]  J. Watanabe,et al.  Conjugation of enzymes on polymer nanoparticles covered with phosphorylcholine groups. , 2004, Biomacromolecules.

[80]  Thomas D. Dziubla,et al.  PEGylation of nanocarrier drug delivery systems: State of the art , 2008 .

[81]  T. Long,et al.  Biomimetic design and performance of polymerizable lipids. , 2009, Accounts of chemical research.

[82]  Ryan Chamberlain,et al.  Targeting Vascular Amyloid in Arterioles of Alzheimer Disease Transgenic Mice With Amyloid &bgr; Protein Antibody-Coated Nanoparticles , 2011, Journal of neuropathology and experimental neurology.

[83]  A. M. Carmona-Ribeiro,et al.  Synthetic bilayer adsorption onto polystyrene microspheres , 1992 .

[84]  Y. Gong,et al.  Tunable cell membrane mimetic surfaces prepared with a novel phospholipid polymer , 2008 .

[85]  K. Ishihara,et al.  Bioabsorbable material-containing phosphorylcholine group-rich surfaces for temporary scaffolding of the vessel wall. , 2009, Tissue engineering. Part C, Methods.

[86]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[87]  Katharina Landfester,et al.  Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. , 2011, ACS nano.

[88]  Michael J. Welch,et al.  In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. , 2010, Bioconjugate chemistry.

[89]  Y. Gong,et al.  Group reorientation and migration of amphiphilic polymer bearing phosphorylcholine functionalities on surface of cellular membrane mimicking coating. , 2008, Journal of biomedical materials research. Part A.

[90]  F. Winnik,et al.  Solution Properties of Phosphorylcholine-Based Hydrophobically Modified Polybetaines in Water and Mixed Solvents† , 2002 .

[91]  Robert Langer,et al.  PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. , 2009, Biomaterials.

[92]  Neetu Singh,et al.  Nanoparticles that communicate in vivo to amplify tumour targeting. , 2011, Nature materials.

[93]  Y. Iwasaki,et al.  Cell-specific delivery of polymeric nanoparticles to carbohydrate-tagging cells. , 2007, Biomacromolecules.

[94]  E. Rozhkova,et al.  Nanoscale Materials for Tackling Brain Cancer: Recent Progress and Outlook , 2011, Advanced materials.

[95]  Qingming Luo,et al.  Biomimetic nanocarrier for direct cytosolic drug delivery. , 2009, Angewandte Chemie.

[96]  C Jeffrey Brinker,et al.  Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery. , 2009, Journal of the American Chemical Society.

[97]  C. Cho,et al.  Gene delivery system based on highly specific recognition of surface-vimentin with N-acetylglucosamine immobilized polyethylenimine. , 2011, Biomaterials.

[98]  R. Ramesh,et al.  Selective targeting of antibody conjugated multifunctional nanoclusters (nanoroses) to epidermal growth factor receptors in cancer cells. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[99]  Robert Langer,et al.  Tissue-specific gene delivery via nanoparticle coating. , 2010, Biomaterials.

[100]  Yuan Yuan,et al.  Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan. , 2009, Biomaterials.

[101]  James C Paulson,et al.  In vivo targeting of B-cell lymphoma with glycan ligands of CD22. , 2010, Blood.

[102]  F. Caruso,et al.  Functionalization of Colloids with Robust Inorganic-Based Lipid Coatings , 2004 .

[103]  K. Ishihara,et al.  2-Methacryloyloxyethyl phosphorylcholine polymer (MPC)-coating improves the transfection activity of GALA-modified lipid nanoparticles by assisting the cellular uptake and intracellular dissociation of plasmid DNA in primary hepatocytes. , 2010, Biomaterials.

[104]  V. Torchilin Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[105]  Mariano Ortega-Muñoz,et al.  Magnetic nanoparticles--templated assembly of protein subunits: a new platform for carbohydrate-based MRI nanoprobes. , 2011, Journal of the American Chemical Society.

[106]  W. J. Duncanson,et al.  ApJ, in press , 1999 .

[107]  K. Ishihara,et al.  Stabilization of phospholipid polymer surface with three-dimensional nanometer-scaled structure for highly sensitive immunoassay. , 2010, Colloids and surfaces. B, Biointerfaces.

[108]  C. Jeffrey Brinker,et al.  Porous nanoparticle supported lipid bilayers (protocells) as delivery vehicles. , 2009, Journal of the American Chemical Society.

[109]  S. Armes,et al.  Synthesis of biocompatible poly[2-(methacryloyloxy)ethyl phosphorylcholine]-coated magnetite nanoparticles. , 2006, Langmuir : the ACS journal of surfaces and colloids.